Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Y Bargieri

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Venomous Animals and Toxins Including Tropical Diseases|May 5, 2020
São Paulo School of Advanced Sciences on Vaccines: an overviewSara Sorgi, Vivian Bonezi, Mariana R Dominguez, et al.
Nature Protocols|September 3, 2011
FLP/FRT-mediated conditional mutagenesis in pre-erythrocytic stages of Plasmodium bergheiCéline Lacroix, Donatella Giovannini, Audrey Combe, et al.
Vaccine|November 26, 2009
CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified proteinCatarina J M Braga, Liliana M Massis, Maria E Sbrogio-Almeida, et al.
ACS Omega|September 25, 2023
Transcriptomics-Guided In Silico Drug Repurposing: Identifying New Candidates with Dual-Stage Antiplasmodial ActivityJoyce V B Borba, Beatriz Rosa de Azevedo, Larissa A Ferreira, et al.
Antimicrobial Agents and Chemotherapy|March 1, 2023
Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei OoklucJuliana Calit, Jessica E Araújo, Bingbing Deng, et al.
Microbes and Infection|June 27, 2006
Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus)Daniela S Rosa, Leo K Iwai, Fanny Tzelepis, et al.
Vaccine|February 23, 2010
Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimuriumDaniel Y Bargieri, Juliana A Leite, Stefanie C P Lopes, et al.
Vaccine|September 23, 2008
New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellinDaniel Y Bargieri, Daniela S Rosa, Catarina J M Braga, et al.
Chemmedchem|November 28, 2020
Artificial Intelligence Applied to the Rapid Identification of New Antimalarial Candidates with Dual-Stage ActivityMarilia N N Lima, Joyce V B Borba, Gustavo C Cassiano, et al.
Future Medicinal Chemistry|September 27, 2019
Chalcones as a basis for computer-aided drug design: innovative approaches to tackle malariaMarilia Nn Lima, Bruno J Neves, Gustavo C Cassiano, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Venomous Animals and Toxins Including Tropical Diseases|May 5, 2020
São Paulo School of Advanced Sciences on Vaccines: an overviewSara Sorgi, Vivian Bonezi, Mariana R Dominguez, et al.
Nature Protocols|September 3, 2011
FLP/FRT-mediated conditional mutagenesis in pre-erythrocytic stages of Plasmodium bergheiCéline Lacroix, Donatella Giovannini, Audrey Combe, et al.
Vaccine|November 26, 2009
CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified proteinCatarina J M Braga, Liliana M Massis, Maria E Sbrogio-Almeida, et al.
ACS Omega|September 25, 2023
Transcriptomics-Guided In Silico Drug Repurposing: Identifying New Candidates with Dual-Stage Antiplasmodial ActivityJoyce V B Borba, Beatriz Rosa de Azevedo, Larissa A Ferreira, et al.
Antimicrobial Agents and Chemotherapy|March 1, 2023
Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei OoklucJuliana Calit, Jessica E Araújo, Bingbing Deng, et al.
Microbes and Infection|June 27, 2006
Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus)Daniela S Rosa, Leo K Iwai, Fanny Tzelepis, et al.
Vaccine|February 23, 2010
Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimuriumDaniel Y Bargieri, Juliana A Leite, Stefanie C P Lopes, et al.
Vaccine|September 23, 2008
New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellinDaniel Y Bargieri, Daniela S Rosa, Catarina J M Braga, et al.
Chemmedchem|November 28, 2020
Artificial Intelligence Applied to the Rapid Identification of New Antimalarial Candidates with Dual-Stage ActivityMarilia N N Lima, Joyce V B Borba, Gustavo C Cassiano, et al.
Future Medicinal Chemistry|September 27, 2019
Chalcones as a basis for computer-aided drug design: innovative approaches to tackle malariaMarilia Nn Lima, Bruno J Neves, Gustavo C Cassiano, et al.
Pageof 4